DE69816964D1 - Combination of glycosyl vitamin P and trehalose to improve blood circulation and muscle stiffness - Google Patents

Combination of glycosyl vitamin P and trehalose to improve blood circulation and muscle stiffness

Info

Publication number
DE69816964D1
DE69816964D1 DE69816964T DE69816964T DE69816964D1 DE 69816964 D1 DE69816964 D1 DE 69816964D1 DE 69816964 T DE69816964 T DE 69816964T DE 69816964 T DE69816964 T DE 69816964T DE 69816964 D1 DE69816964 D1 DE 69816964D1
Authority
DE
Germany
Prior art keywords
trehalose
combination
blood circulation
improve blood
muscle stiffness
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69816964T
Other languages
German (de)
Other versions
DE69816964T2 (en
Inventor
Shigeharu Fukuda
Toshio Miyake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Original Assignee
Hayashibara Seibutsu Kagaku Kenkyujo KK
Hayashibara Biochemical Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK, Hayashibara Biochemical Laboratories Co Ltd filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK
Publication of DE69816964D1 publication Critical patent/DE69816964D1/en
Application granted granted Critical
Publication of DE69816964T2 publication Critical patent/DE69816964T2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE69816964T 1997-12-09 1998-11-23 Combination of glycosyl vitamin P and trehalose to improve blood circulation and muscle stiffness Expired - Lifetime DE69816964T2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP35405997 1997-12-09
JP35405997A JP4295840B2 (en) 1997-12-09 1997-12-09 Blood circulation improving agent

Publications (2)

Publication Number Publication Date
DE69816964D1 true DE69816964D1 (en) 2003-09-11
DE69816964T2 DE69816964T2 (en) 2004-06-17

Family

ID=18435025

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69816964T Expired - Lifetime DE69816964T2 (en) 1997-12-09 1998-11-23 Combination of glycosyl vitamin P and trehalose to improve blood circulation and muscle stiffness

Country Status (6)

Country Link
US (1) US5981498A (en)
EP (1) EP0938899B1 (en)
JP (1) JP4295840B2 (en)
KR (1) KR100588952B1 (en)
DE (1) DE69816964T2 (en)
TW (1) TW533077B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4203159B2 (en) * 1997-12-09 2008-12-24 株式会社林原生物化学研究所 Nerve function regulator
WO2001014396A1 (en) * 1999-08-19 2001-03-01 Korea Research Institute Of Bioscience And Biotechnology Flavonoids derived from citrus peels as collagen-induced platelet aggregation inhibitor
US6159943A (en) * 1999-09-24 2000-12-12 Bioenergy, Inc. Use of ribose to prevent cramping and soreness in muscles
EP1268305B1 (en) 2000-03-21 2007-09-12 Suzanne Jaffe Stillman Infusion packet with useful and decorative elements, support member, delivery system and method
US8642051B2 (en) 2000-03-21 2014-02-04 Suzanne Jaffe Stillman Method of hydration; infusion packet system(s), support member(s), delivery system(s), and method(s); with business model(s) and Method(s)
JP4754066B2 (en) * 2000-12-22 2011-08-24 株式会社林原生物化学研究所 Anti-joint disorder
JP4397142B2 (en) * 2001-11-20 2010-01-13 株式会社林原生物化学研究所 Reactive oxygen scavenging reduction inhibitor
US20050065030A1 (en) * 2001-11-20 2005-03-24 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Reduction inhibitory agent for active oxygen eliminating activity
FR2841472B1 (en) * 2002-06-28 2006-02-24 Agronomique Inst Nat Rech NUTRITIONAL OR THERAPEUTIC COMPOSITION CONTAINING THE HESPERIDINE COMPOUND OR ONE OF ITS DERIVATIVES
KR101054913B1 (en) * 2003-12-31 2011-08-05 주식회사 삼양제넥스 Composition for preventing and treating hyperlipidemia, arteriosclerosis and liver disease, including phytosterol, hesperidin and rutin
JP5000884B2 (en) * 2004-12-02 2012-08-15 江崎グリコ株式会社 Method for synthesizing hesperetin inclusion compound and naringenin inclusion compound
AT501221A1 (en) * 2005-01-14 2006-07-15 Hermine Dr Engl ACTIVE COMPOUND
AT501682A1 (en) * 2005-01-14 2006-10-15 Hermine Dr Engl METHOD FOR PRODUCING AN ACTIVE SUBSTANCE MIXTURE
WO2008102563A1 (en) 2007-02-23 2008-08-28 Next21 K.K. Therapeutic or prophylactic agent for vasoconstriction
JP2009007256A (en) * 2007-06-26 2009-01-15 Kao Corp Nadh/nadph oxidase inhibitor
JP2009007313A (en) * 2007-06-29 2009-01-15 Lion Corp Amyotrophy inhibitor
JPWO2010029913A1 (en) * 2008-09-11 2012-02-02 株式会社林原生物化学研究所 Kiln improver
US9901648B2 (en) 2012-01-27 2018-02-27 The Regents Of The University Of California Stabilization of biomolecules using sugar polymers
US9392814B2 (en) 2014-06-06 2016-07-19 Nicholas J. Singer Delivery system for drinks
USD773313S1 (en) 2015-06-23 2016-12-06 Nicholas J. Singer Package
JP7140533B2 (en) * 2017-08-30 2022-09-21 東洋精糖株式会社 Composition for ameliorating asthenopia or for ameliorating decreased focusing ability of eyes
JP6826347B2 (en) * 2018-05-23 2021-02-03 長崎県公立大学法人 Compositions for improving poor circulation, improving stiff shoulders, recovering from fatigue or improving sleep, foods, drugs, composition kits containing them, and methods for producing the compositions.

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR8012M (en) * 1967-10-20 1970-07-27
SU681841A1 (en) * 1978-03-06 1981-03-07 Московский Ордена Ленина И Ордена Трудового Коасного Знаменимедецинский Институт Им.И.M.Сеченова Method of rutin production
ATE118550T1 (en) * 1989-03-08 1995-03-15 Hayashibara Biochem Lab PREPARATION AND USES OF ALPHA-GLYCOSYL RUTIN.
JP3177892B2 (en) * 1989-04-15 2001-06-18 株式会社林原生物化学研究所 Production method of α-glycosylrutin and its use
JP2926411B2 (en) * 1989-03-08 1999-07-28 株式会社林原生物化学研究所 Production method of α-glycosyl rutin and its use
JP3060227B2 (en) * 1989-06-03 2000-07-10 株式会社林原生物化学研究所 α-Glycosyl hesperidin, its production method and use
JP3194145B2 (en) * 1989-09-28 2001-07-30 株式会社林原生物化学研究所 4G-α-D-glucopyranosylrutin, production method and use thereof
JP2926432B2 (en) * 1990-06-11 1999-07-28 株式会社林原生物化学研究所 Hair restorer
JP2896598B2 (en) * 1990-10-06 1999-05-31 株式会社林原生物化学研究所 Lactoneotrehalose, its production method and use
JP3082094B2 (en) * 1990-11-15 2000-08-28 株式会社林原生物化学研究所 Method for producing neotrehalose and its use
US5494667A (en) * 1992-06-04 1996-02-27 Kabushiki Kaisha Hayahibara Topically applied hair restorer containing pine extract
ES2136115T3 (en) * 1992-12-28 1999-11-16 Hayashibara Biochem Lab ENZYME FORMING NON-REDUCING SUCCARIDS, AND THEIR PREPARATION AND USES.
JP3559585B2 (en) * 1993-06-03 2004-09-02 株式会社林原生物化学研究所 Trehalose-releasing enzyme, its production method and use
JPH0725761A (en) * 1993-07-09 1995-01-27 Kureha Chem Ind Co Ltd Agent for protecting cartilage
JP3557272B2 (en) * 1994-02-23 2004-08-25 株式会社林原生物化学研究所 Recombinant enzyme, its production method and use
DE69510116T2 (en) * 1994-02-23 1999-11-18 Hayashibara Biochem Lab Non-reducing saccharide-forming enzyme, this coding DNA, and their preparations and uses
EP0671470B9 (en) * 1994-03-07 2004-11-03 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Trehalose releasing enzyme, DNA encoding therefor, their preparation and uses
JP3559609B2 (en) * 1994-03-07 2004-09-02 株式会社林原生物化学研究所 Recombinant enzyme, its production method and use
JP3557277B2 (en) * 1994-06-25 2004-08-25 株式会社林原生物化学研究所 Thermostable trehalose releasing enzyme, its production method and use
JP3793590B2 (en) * 1994-06-27 2006-07-05 株式会社林原生物化学研究所 Non-reducing saccharides, production method and use thereof
JP3557287B2 (en) * 1994-06-24 2004-08-25 株式会社林原生物化学研究所 Thermostable non-reducing saccharide-forming enzyme, its production method and use
US5714368A (en) * 1994-06-24 1998-02-03 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Thermostable non-reducing saccharide-forming enzyme its production and uses
EP0693558B1 (en) * 1994-07-19 2002-12-04 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Trehalose and its production and use
JP3616166B2 (en) * 1994-07-19 2005-02-02 株式会社林原生物化学研究所 Trehalose and its production method and use
JP3557288B2 (en) * 1994-07-21 2004-08-25 株式会社林原生物化学研究所 Recombinant thermostable enzyme that produces non-reducing carbohydrates with terminal trehalose structure from reducing starch sugars
JP3557289B2 (en) * 1994-07-21 2004-08-25 株式会社林原生物化学研究所 Recombinant thermostable enzyme that releases trehalose from non-reducing carbohydrates
JP3810457B2 (en) * 1994-10-01 2006-08-16 株式会社林原生物化学研究所 Recombinant thermostable enzyme that converts maltose to trehalose
KR0182395B1 (en) * 1995-12-08 1999-04-01 권계홍 Heat treatment of protein liquid using trehalose as a stabilizer
EP0868916A3 (en) * 1997-03-04 2004-09-15 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Reduction inhibitory agent for active-oxygen eliminating activity
JP4203159B2 (en) * 1997-12-09 2008-12-24 株式会社林原生物化学研究所 Nerve function regulator

Also Published As

Publication number Publication date
EP0938899A2 (en) 1999-09-01
JP4295840B2 (en) 2009-07-15
US5981498A (en) 1999-11-09
EP0938899A3 (en) 2000-09-20
KR100588952B1 (en) 2006-10-13
DE69816964T2 (en) 2004-06-17
KR19990062596A (en) 1999-07-26
JPH11171778A (en) 1999-06-29
TW533077B (en) 2003-05-21
EP0938899B1 (en) 2003-08-06

Similar Documents

Publication Publication Date Title
DE69816964D1 (en) Combination of glycosyl vitamin P and trehalose to improve blood circulation and muscle stiffness
ID29198A (en) USE OF URIDIN 5'-DIFOSPHATE AND ITS EQUATION TO TREAT LUNG DISEASE
DE69728408D1 (en) NON-INVASIVE IMAGE OF BIOLOGICAL TISSUE
ID28111A (en) METHODS TO IMPROVE SKIN HEALTH
ID25504A (en) PREVENTION AND TREATMENT OF AMILOIDOGENIC DISEASE
ATE386439T1 (en) USES OF OIL BODY
ID26725A (en) SUBSTANCE TO PREVENT AND TREAT SKIN DISEASE
DE69712003D1 (en) Modification of xylanase to improve thermophilicity, alkophilicity and thermostability
DE69831755D1 (en) OPTOACUSTIC CONSTANCES AND METHOD OF USE
DE69832229D1 (en) Cardiac pacing system with improved recognition of evoked response and repolarization signal
DE59811786D1 (en) Means to increase the formability and shine of hair
DE69813935D1 (en) Use of retinoids to induce skin pigmentation
NO985065D0 (en) Use of Protein Kinase C Inhibitors to Improve the Clinical Effect of Oncolytic Agents and Radiation Therapy
DE69806801D1 (en) GALENIC PREPARATION FOR THE PREVENTION AND TREATMENT OF HEPATOCARCINOMA
ATE228845T1 (en) INJECTION FORMULATIONS OF AVERMECTINS AND MILBEMYCINS
PT1017408E (en) USE OF TETRA-HYDROLYSTERATIN IN TREATMENT OF TYPE II DIABETES
DE69934889D1 (en) PREPARATION AND PURIFICATION OF DIBORANESE
DE69808266D1 (en) PRODUCTION AND USE OF ALPHA KETOAMIDE DERIVATIVES AND ARRANGEMENTS
PT935692E (en) TREATMENT OF TISSUE WITH CELLULASE AND OXIDOREDUTASE
PT951465E (en) ALPHA-AMINO ACID AMIDES PREPARATION OF THE SAME AND THERAPEUTIC UTILIZATION OF THE SAME
DE69918447D1 (en) ANTIVIRAL COMBINATIONS OF LAMIVUDIN AND ADEFOVIR
DE69712334D1 (en) PESTICIDAL COMPOSITIONS OF CYPRODINIL AND MYCLOBUTANIL
DE69831223D1 (en) FREEZE-DRIED COMPOSITION OF THE HUMAN, MORPHOGOUS BONE PROTEIN MP52
DK0939622T3 (en) Porous microcapsules and their use as therapeutic and diagnostic carriers
DE69836559D1 (en) AMINOALKYLPHENOL DERIVATIVES FOR THE TREATMENT OF DEPRESSION AND MEMORY FUNCTIONAL DISORDER

Legal Events

Date Code Title Description
8364 No opposition during term of opposition